IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 20 filers reported holding IO BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,026 | -28.0% | 68,813 | -0.2% | 0.00% | – |
| Q2 2023 | $134,793 | +66.4% | 68,948 | +59.6% | 0.00% | – |
| Q1 2023 | $80,991 | +21.2% | 43,195 | +48.6% | 0.00% | – |
| Q4 2022 | $66,838 | +11.4% | 29,060 | +31.7% | 0.00% | – |
| Q3 2022 | $60,000 | -46.9% | 22,060 | -8.5% | 0.00% | – |
| Q2 2022 | $113,000 | +29.9% | 24,109 | +46.2% | 0.00% | – |
| Q1 2022 | $87,000 | +52.6% | 16,487 | +84.0% | 0.00% | – |
| Q4 2021 | $57,000 | – | 8,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,015,545 | $6,936 | 0.80% |
| Samsara BioCapital, LLC | 1,008,437 | $2,319,405 | 0.50% |
| Novo Holdings A/S | 3,277,932 | $7,539,244 | 0.47% |
| Avoro Capital Advisors LLC | 2,055,883 | $4,728,531 | 0.07% |
| RA Capital Management | 1,127,260 | $2,592,698 | 0.05% |
| Newtyn Management, LLC | 90,000 | $207,000 | 0.04% |
| PFM Health Sciences, LP | 507,640 | $1,167,572 | 0.04% |
| Psagot Value Holdings Ltd. / (Israel) | 40,846 | $94 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $304,060 | 0.01% |
| Cannell Capital | 12,594 | $28,966 | 0.01% |